CAW
ABMD

Cornerstone Advisors (Washington)’s Abiomed Inc ABMD Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-196
Closed -$51K – 1445
2019
Q2 		$51K Buy
196
+31
+19% +$8.22K ﹤0.01% 400
2019
Q1 		$47K Buy
165
+80
+94% +$26.6K ﹤0.01% 385
2018
Q4 		$28K Buy
85
+64
+305% +$22.2K 0.01% 439
2018
Q3 		$9K Buy
21
+17
+425% +$6.7K 0.01% 673
2018
Q2 		$2K Sell
4
-4
-50% -$1.45K ﹤0.01% 887
2018
Q1 		$2K Buy
+8
New +$2.03K ﹤0.01% 862

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Cornerstone Advisors (Washington)'s ABMD Position: Q3 2019 in Review

Cornerstone Advisors (Washington) sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 196 shares — an estimated $51K sold.

Cornerstone Advisors (Washington) first reported a position in ABMD in Q1 2018 and held it in 6 quarters. The position peaked at $51K in Q2 2019. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Cornerstone Advisors (Washington) reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 196 Abiomed Inc shares in Q3 2019, an estimated $51K.
  • Cornerstone Advisors (Washington) first reported a position in Abiomed Inc in Q1 2018 and held it in 6 quarters.
  • Cornerstone Advisors (Washington)'s Abiomed Inc position peaked at $51K in Q2 2019.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2019, filed 23 Oct 2019.